Bayer: Anti-GM views unscientific

Dr Marijn Dekkers, chairman of the management group of German pharmaceuticals group Bayer discusses eurozone certainty, pressure on drugs prices, problems in India with patents and opposition to genetically-modified food. He was interviewed by the FT's Andrew Jack.